Artivion (AORT) Tops Q4 EPS by 6c, provides guidance

Artivion (NYSE: AORT) reported Q4 EPS of $0.00, $0.06 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $97.3 million versus the consensus estimate of $100.82 million.

GUIDANCE:

Artivion sees FY2025 revenue of $420-435 million, versus the consensus of $430.2 million.

For earnings history and earnings-related data on Artivion (AORT) click here.

You May Also Be Interested In

• EyePoint Pharmaceuticals (EYPT) call put ratio 1.4 calls to 1 put as share price up 8.9%
• Prenetics Global (PRE) Tops Q2 EPS by 18c
• Artivion Inc. (AORT) PT Raised to $40 at Canaccord